CNC CENTENE CORP
Hospital & Medical Service Plans · NYSE · SEC CIK 1071739 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.7%
TTM net income YoY127.6%
TTM EPS YoY127.3%
Revenue 3-yr CAGR10.7%
Net income 3-yr CAGR-15.8%
Margins
Gross margin7.9%
Operating margin0.5%
Net margin0.7%
FCF margin1.9%
EBITDA margin0.9%
Returns
ROE6.8%
ROA1.8%
ROIC (approx.)4.0%
Asset turnover2.53x
Leverage & solvency
Liabilities / assets71.9%
Debt / equity0.70x
Current ratio1.16x
Interest coverage1.59x
Cash quality & payout
Operating cash flow / net income3.24x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Cost of revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B |
| Gross profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B |
| SG&A expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B |
| Operating income | -$7.62B | $3.17B | $2.93B | $1.32B | $1.78B |
| Interest expense | $678.00M | $702.00M | $725.00M | $665.00M | $665.00M |
| Pretax income | -$6.73B | $4.26B | $3.60B | $1.96B | $1.81B |
| Income tax | -$51.00M | $963.00M | $899.00M | $760.00M | $477.00M |
| Net income | -$6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| EBITDA | -$6.35B | $4.42B | $4.22B | $2.75B | $3.12B |
| EPS (basic) | -13.53 | 6.33 | 4.97 | 2.09 | 2.31 |
| EPS (diluted) | -13.53 | 6.31 | 4.95 | 2.07 | 2.28 |
| Weighted avg. shares (diluted) | 493.12M | 523.74M | 545.70M | 582.04M | 590.52M |
| Balance sheet | |||||
| Cash & equivalents | $17.89B | $14.16B | $17.19B | $12.33B | $13.21B |
| Short-term investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B |
| Current assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B |
| PP&E, net | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B |
| Total assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B |
| Current liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B |
| Short-term debt | $50.00M | $110.00M | $119.00M | $82.00M | $267.00M |
| Long-term debt | $17.35B | $18.42B | $17.71B | $17.94B | $18.57B |
| Total debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B |
| Total liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B |
| Shareholders' equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B |
| Net debt | -$487.00M | $4.38B | $636.00M | $5.69B | $5.62B |
| Shares outstanding | 491.76M | 495.91M | 534.48M | 550.75M | 582.48M |
| Cash flow statement | |||||
| Operating cash flow | $5.09B | $154.00M | $8.05B | $6.26B | $4.21B |
| Capital expenditure | $767.00M | $644.00M | $799.00M | $1.00B | $910.00M |
| Free cash flow | $4.32B | -$490.00M | $7.25B | $5.26B | $3.29B |
| Investing cash flow | $472.00M | -$1.05B | -$1.19B | -$2.92B | -$3.30B |
| Financing cash flow | -$1.62B | -$2.41B | -$1.66B | -$4.20B | $1.36B |
| Depreciation & amortization | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B |
| Stock-based compensation | $204.00M | $212.00M | $216.00M | $234.00M | $203.00M |
| Share buybacks | $475.00M | $3.12B | $1.63B | $3.10B | $297.00M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.